Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.
Koehler VF, Adam P, Fuss CT, Jiang L, Berg E, Frank-Raue K, Raue F, Hoster E, Knösel T, Schildhaus HU, Negele T, Siebolts U, Lorenz K, Allelein S, Schott M, Spitzweg C, Kroiss M; German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid Glands.
Koehler VF, et al. Among authors: raue f.
Cancers (Basel). 2022 Jul 13;14(14):3405. doi: 10.3390/cancers14143405.
Cancers (Basel). 2022.
PMID: 35884466
Free PMC article.